Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| Afatinib | Afatinib irreversibly inhibits EGFR/HER2 including EGFR, EGFR(L858R), EGFR(L858R/T790M) and HER2. It is 100-fold more active against Gefitinib-resistant L858R-T790M EGFR mutant. Uses: Antineoplastic agents. Group: Pharmaceutical. CAS No. 850140-72-6. Pack Sizes: 500 mg. Product ID: B0084-258486. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Afatinib-[d6] | Afatinib-[d6] is the labelled analogue of Afatinib. Afatinib is a medication approved for the treatment of metastatic non-small cell lung cancer (NSCLC) that has certain EGFR mutations. It acts via inhibiting EGFR and HER2. Group: Pharmaceutical. CAS No. 1313874-96-2. Pack Sizes: 5 mg. Product ID: BLP-011554. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Afatinib dimaleate | Afatinib Dimaleate irreversibly inhibits EGFR/HER2 including EGFR(wt), EGFR(L858R), EGFR(L858R/T790M) and HER2 with IC50 of 0.5 nM, 0.4 nM, 10 nM and 14 nM, respectively. Group: Pharmaceutical. CAS No. 850140-73-7. Pack Sizes: 500 mg. Product ID: NP3632. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Afatinib Impurities | Afatinib Impurities are critical for assessing the quality and safety of afatinib, a tyrosine kinase inhibitor used in treating non-small cell lung cancer. These impurities provide insights into the drug's stability and degradation pathways, ensuring therapeutic efficacy and compliance with rigorous pharmaceutical standards. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Afatinib Impurity 52 | Afatinib Impurity 52 is an impurity of Afatinib, a drug used to treat non-small cell lung cancer (NSCLC). Group: Pharmaceutical. CAS No. 618061-76-0. Pack Sizes: 100 mg. Product ID: B2699-424124. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Afatinib Impurity B | An analogue of Afatinib, a medication used to treat non-small cell lung carcinoma (NSCLC). Group: Pharmaceutical. CAS No. 314771-76-1. Pack Sizes: 10 mg. Product ID: B2694-466202. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Afatinib Impurity C | An impurity of Afatinib, a medication used to treat non-small cell lung carcinoma (NSCLC). Group: Pharmaceutical. CAS No. 945553-91-3. Pack Sizes: 10 mg. Product ID: B2694-466206. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Afatinib Impurity D | An analogue of Afatinib, a medication indicated for the treatment of non-small cell lung carcinoma (NSCLC). Group: Pharmaceutical. CAS No. 1680184-59-1. Pack Sizes: 5 mg. Product ID: B2694-466207. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Afatinib Impurity I | An impurity of Afatinib, a medication used to treat non-small cell lung carcinoma (NSCLC). Group: Pharmaceutical. CAS No. 1637254-93-3. Pack Sizes: 2.5 mg. Product ID: B1370-377782. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Afatinib Impurity J | An impurity of Afatinib, a medication used to treat non-small cell lung carcinoma (NSCLC). Group: Pharmaceutical. CAS No. 1456696-14-2. Pack Sizes: 10 mg. Product ID: B2694-466213. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 4-N-(3-Chloro-4-fluorophenyl)-7-[(3R)-oxolan-3-yl]oxyquinazoline-4,6-diamine | An impurity of Afatinib, a medication used to treat non-small cell lung carcinoma (NSCLC). Group: Pharmaceutical. CAS No. 402855-03-2. Pack Sizes: 10 mg. Product ID: B2694-292473. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-[4-[ (3-Chloro-4-fluorophenyl)amino]-7-[[ (3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4- (dimethylamino)-2-butenamide | N-[4-[ (3-Chloro-4-fluorophenyl)amino]-7-[[ (3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4- (dimethylamino)-2-butenamide is an impurity of Afatinib, which is a tyrosine kinase inhibitor used to treat non-small cell lung carcinoma (NSCLC). Uses: Antineoplastic agents. Group: Pharmaceutical. CAS No. 439081-18-2. Pack Sizes: 500 mg. Product ID: B0084-092426. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
